Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1998 1
2002 1
2004 1
2007 1
2008 1
2009 1
2012 1
2016 1
2017 1
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
A modified scleroderma skin scoring method.
Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC. Kahaleh MB, et al. Among authors: huffstutter je. Clin Exp Rheumatol. 1986 Oct-Dec;4(4):367-9. Clin Exp Rheumatol. 1986. PMID: 3791722
MACRA: Big Fix or Big Problem?
Huffstutter JE. Huffstutter JE. Ann Intern Med. 2018 Feb 6;168(3):235. doi: 10.7326/L17-0627. Ann Intern Med. 2018. PMID: 29404587 No abstract available.
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial.
Schiff M, Pritchard C, Huffstutter JE, Rodriguez-Valverde V, Durez P, Zhou X, Li T, Bahrt K, Kelly S, Le Bars M, Genovese MC. Schiff M, et al. Among authors: huffstutter je. Ann Rheum Dis. 2009 Nov;68(11):1708-14. doi: 10.1136/ard.2008.099218. Epub 2008 Dec 15. Ann Rheum Dis. 2009. PMID: 19074911 Free PMC article. Clinical Trial.
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF; PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial. Shergy WJ, et al. Among authors: huffstutter je. J Rheumatol. 2002 Apr;29(4):667-77. J Rheumatol. 2002. PMID: 11950005 Clinical Trial.
12 results